Public Company News

XTEP Sponsors Vietnamese Top Runner Phạm Thị Hồng Lệ to Win VnExpress Marathon Ha Long 2025, Demonstrating Brand Strength and Professionalism

HA LONG, Vietnam, June 2, 2025 /PRNewswire/ -- Professional sportswear brand XTEP has sponsored top runner Phạm Thị Hồng Lệ in the VnExpress Marathon Ha Long 2025 on June 1, who won the competition with 02:59:31. The event, attracting thousands of elite runners, also saw XTEP-sponsored runners se...

2025-06-02 19:29 3069

Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil

New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence LONDON, June 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, tod...

2025-06-02 15:00 2027

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

PETACH TIKVA, Israel, June 2, 2025 /PRNewswire/ -- ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical iso...

2025-06-02 09:00 3163

TuniTuni Opens New Storytelling Kids' Gym in Shek Mun, Hong Kong

HONG KONG, June 2, 2025 /PRNewswire/ -- TuniTuni, the beloved Korean kids' gym brand, is thrilled to announce the opening of its second Hong Kong center in Shek Mun on 1st June 2025. Located at Unit N, P. 19/F Kings Wing Plaza 2, No 1 On Kwan Street, Shatin, this new facility follows the phenomen...

2025-06-02 08:53 4345

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

SHANGHAI, June 1, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of the pivotal Phase II clinical trial in China (CT041-ST-01, NCT04581473) investigating satricabtagene au...

2025-06-02 08:15 2180

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer

SAN FRANCISCO, and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2025-06-02 08:00 4196

China Liberal Education Holdings Limited Announces Suspension of Nasdaq Trading

BEIJING, June 1, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), aChina-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that onMay 30, 2025, th...

2025-06-01 20:00 4307

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma

SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, opht...

2025-06-01 09:39 5733

Zeekr Group Announces May 2025 Delivery Update

HANGZHOU, China, June 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results forMay 2025. In May, Zeekr Group delivered a total of 46,538 vehicles...

2025-06-01 09:30 3327

9F Inc. Announces Receipt of Nasdaq Notification Regarding Late Filing of Form 20-F

BEIJING, May 30, 2025 /PRNewswire/ -- 9F Inc. ("9F" or the "Company") (Nasdaq: JFU), a digital technology service provider aiming to empower institutional partners with advanced financial technologies, today announced that it received a notification letter datedMay 23, 2025 (the "Notification Let...

2025-05-31 04:30 5336

Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG)

SHANGHAI, May 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by its wholly-owned subsidiary T-mab has officially obtaine...

2025-05-30 22:00 2724

Dynatrace Names DXC Global Partner of the Year

ASHBURN, Va., May 30, 2025 /PRNewswire/ -- DXC Technology, a leading Fortune 500 global technology services provider, today announced it has been named Global Partner of the Year at the Dynatrace Amplify Partner Sales Kickoff. The award recognizes DXC's 15-year strategic collaboration with Dynatra...

2025-05-30 21:00 3362

NYSE Content Advisory: Pre-Market update + April inflation data released

NEW YORK, May 30, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on May 30th * Sto...

2025-05-30 20:55 4351

Noah's Q1 2025 Earnings Show YoY and Sequential Growth in Profitability and Operating Margin Expansion

SHANGHAI, May 30, 2025 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for global Chinese hig...

2025-05-30 20:25 5400

Asia-Pacific Marine Engine Leader Weichai Launches Premium WH17 Marine Power, Earning Recognition from Korean Customers

SEOUL, South Korea, May 30, 2025 /PRNewswire/ -- As a leading brand in the marine engine market in the Asia-Pacific region, Weichai continues to strengthen its strategic presence in the Korean market. In recent years, it has successfully launched the WH17 series—a new generation of premium marine...

2025-05-30 19:03 4220

mF International Limited Announces Results of Annual General Meeting

HONG KONG, May 30, 2025 /PRNewswire/ -- mF International Limited (the "Company" or "mF International") (Nasdaq: MFI), aHong Kong-based experienced financial trading solution provider, today announced the results of its annual general meeting of shareholders held inHong Kong on May 30, 2025. At t...

2025-05-30 19:00 4010

Qudian Inc. Reports First Quarter 2025 Unaudited Financial Results

XIAMEN, China, May 30, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company inChina, today announced its unaudited financial results for the quarter endedMarch 31, 2025. First Quarter 2025 Financial Highlights: * Total revenue...

2025-05-30 18:00 4458

So-Young Announces Plan to Implement ADS Ratio Change

BEIJING, May 30, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform inChina connecting consumers with online services and offline treatments, today announced that the Company plans to change the ratio of the Americ...

2025-05-30 17:00 3924

OLIVE YOUNG SUMMER SALE FOR INTERNATIONAL CUSTOMERS BEGINS

SEOUL, South Korea, May 30, 2025 /PRNewswire/ -- CJ Olive Young, Korea's leading beauty and health retailer, has officially launched the OLIVE YOUNG SUMMER SALE on its international mobile app and website. Formerly known as the "Big Bang Sale," this major promotion is now part of Olive Young's ne...

2025-05-30 15:47 4768

GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal

YONGIN, South Korea, May 30, 2025 /PRNewswire/ -- GC Biopharma, a South Korean pharmaceutical company, announced that the Phase 3 clinical trial results for Hunterase (idursulfase beta), its investigational drug for Hunter Syndrome (MPS II), have been published in Genetics in Medicine, an SCIE-in...

2025-05-30 15:02 2599